| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 13, 2004
From the Masonic Medical Research Laboratory, Utica, NY. * To whom correspondence should be addressed. E-mail: ca{at}mmrl.edu.
Background--The short-QT syndrome is a new clinical entity characterized by corrected QT intervals <300 ms and a high incidence of ventricular tachycardia (VT) and fibrillation (VF). Gain-of-function mutations in the gene for outward potassium currents have been shown to underlie the congenital syndrome. The present study examined the cellular basis of VT/VF in an experimental model associated with short QT intervals created with a potassium channel activator. Methods and Results--Transmembrane action potentials from epicardial and M regions, 4 transmural unipolar electrograms, and a pseudo-ECG were simultaneously recorded in canine arterially perfused left ventricular wedge preparations. At a basic cycle length of 2000 ms, pinacidil (2 to 3 µmol/L) abbreviated the QT interval from 303.7±5.4 to 247.3±6.9 ms (mean±SEM, P<0.0001). The maximal transmural dispersion of repolarization (TDRmax) increased from 27.0±3.8 to 64.9±9.2 ms (P<0.01), and an S2 applied to the endocardium induced a polymorphic VT (pVT) in 9 of 12 wedge preparations (P<0.01). Addition of isoproterenol (100 nmol/L, n=5) led to greater abbreviation of the QT interval, a further increase in TDRmax (from 55.4±13.7 to 69.7±8.3 ms), and more enduring pVT. TDRmax was correlated significantly with the Tpeak-Tend interval under all conditions. The effects of pinacidil were completely reversed by glybenclamide (10 µmol/L, n=4) and partially reversed by E4031 (5 µmol/L, n=5), which prevented induction of pVT in 3 of 5 preparations. Conclusions--Our data suggest that heterogeneous abbreviation of the action potential duration among different cell types spanning the ventricular wall creates the substrate for the genesis of VT under conditions associated with short QT intervals.
Revised on July 1, 2004
Accepted on August 3, 2004
Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome
Fabrice Extramiana MD and Charles Antzelevitch PhD*
This article has been cited by other articles:
![]() |
E. H. Medei, J. H.M. Nascimento, R. C. Pedrosa, L. Barcellos, M. O. Masuda, S. Sicouri, M. V. Elizari, and A. C. Campos de Carvalho Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration Europace, July 1, 2008; 10(7): 868 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ghelfi, C. R. Rhoden, G. A. Wellenius, J. Lawrence, and B. Gonzalez-Flecha Cardiac Oxidative Stress and Electrophysiological Changes in Rats Exposed to Concentrated Ambient Particles are Mediated by TRP-Dependent Pulmonary Reflexes Toxicol. Sci., April 1, 2008; 102(2): 328 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fischer, R. Dechend, A. Gapelyuk, E. Shagdarsuren, K. Gruner, A. Gruner, P. Gratze, F. Qadri, M. Wellner, A. Fiebeler, et al. Angiotensin II-induced sudden arrhythmic death and electrical remodeling Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1242 - H1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, G. D. Pollevick, J. M. Cordeiro, O. Casis, M. C. Sanguinetti, Y. Aizawa, A. Guerchicoff, R. Pfeiffer, A. Oliva, B. Wollnik, et al. Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death Circulation, January 30, 2007; 115(4): 442 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Giustetto, F. Di Monte, C. Wolpert, M. Borggrefe, R. Schimpf, P. Sbragia, G. Leone, P. Maury, O. Anttonen, M. Haissaguerre, et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications Eur. Heart J., October 2, 2006; 27(20): 2440 - 2447. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schimpf, C. Wolpert, F. Gaita, C. Giustetto, and M. Borggrefe Short QT syndrome Cardiovasc Res, August 15, 2005; 67(3): 357 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Cardiac repolarization. The long and short of it Europace, January 1, 2005; 7(s2): S3 - S9. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |